AHR and pulmonary arterial hypertension: This consistency across different PAH metabolites and health endpoints suggests that nonlinear dose responses may be a general feature of PAH toxicity, warranting further investigation into shared biological pathways, such as aryl hydrocarbon receptor (AhR)-mediated oxidative stress or metabolic enzyme saturation effects.